Related Experiment Video
Updated: Jun 1, 2026

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform
Published on: May 10, 2024
First-bite syndrome in oncologic patients
Tiago Porfírio Costa1, Carlos Eugenio Nabuco de Araujo2, Joana Filipe2
1Department of Otorhinolaryngology II, Pulido Valente Hospital, North Lisbon Hospital Center, Alameda das Linhas de Torres, 117, 1769-001, Lisbon, Portugal. tiagoporfiriocosta@gmail.com.
First-bite syndrome (FBS), a painful complication of neck surgery, unexpectedly improved with radiotherapy in two oncologic patients. This suggests radiotherapy may be a novel treatment for refractory FBS.
Area of Science:
- Oncology
- Otolaryngology
- Pain Management
Background:
- First-bite syndrome (FBS) is a debilitating complication following parapharyngeal space surgery, characterized by sharp pain in the parotid or mandibular region at the onset of meals.
- Its pathogenesis involves selective sympathetic denervation of the parotid gland, with current treatments yielding poor outcomes.
- FBS is frequently misdiagnosed and significantly impacts patient quality of life.
Observation:
- Two patients undergoing major cervical oncologic surgeries (extended radical neck dissection and external carotid artery ligation) developed refractory FBS post-operatively.
- Conventional medical treatments for FBS were ineffective in these patients.
- Both patients experienced unexpected symptom improvement during external adjuvant radiotherapy, remaining asymptomatic for 7 and 10 months.
Findings:
- Radiotherapy demonstrated a significant positive effect on FBS symptoms in two oncologic patients.
- This observation challenges the conventional understanding of FBS treatment and suggests a potential new therapeutic avenue.
- The study highlights the need to consider radiotherapy in managing refractory FBS, particularly in the oncologic population.
Implications:
- Radiotherapy may represent a novel treatment modality for refractory first-bite syndrome, especially in patients with a history of head and neck cancer surgery.
- Further research is warranted to elucidate the pathophysiological mechanisms underlying radiotherapy's efficacy in FBS.
- This finding could lead to improved management strategies and enhanced quality of life for patients suffering from this often-misunderstood condition.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...